- Lobbying
- Lobbying by Consumer Healthcare Products Association
Lobbying Relationship
Bills mentioned
H.R.3590: Patient Protection and Affordable Care Act
Sponsor: Charles B. Rangel (D-N.Y.)
H.R.1259: Dextromethorphan Distribution Act of 2009
Sponsor: Fred Upton (R-Mich.)
S.1383: Dextromethorphan Abuse Reduction Act of 2009
Sponsor: Richard J. Durbin (D-Ill.)
S.882: Drug and Device Accountability Act of 2009
Sponsor: Edward M. Kennedy (D-Mass.)
H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...
Sponsor: John D. Dingell (D-Mich.)
H.R.3200: America's Affordable Health Choices Act of 2009
Sponsor: John D. Dingell (D-Mich.)
H.R.970: Dextromethorphan Distribution Act of 2007
Sponsor: Fred Upton (R-Mich.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Eric Rasmussen | SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000 |
Rosemary Becchi | Tax Counsel, Senate Finance Committee, 1995-1997 |
Darryl Nirenberg | PSSenAgCom83-87;CDSDSenFRCom87-91;CSSenHelms81-95 |
David Farber | n/a |
Kathleen Strottman | n/a |
Todd Tuten | n/a |
Karen Thiel | n/a |
Paul Rubin | n/a |
Jean McCue | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. Senate
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate